ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells.
Saved in:
| Title: | ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells. |
|---|---|
| Authors: | Munshi M; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Liu X; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Kofides A; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Tsakmaklis N; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Hunter ZR; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Guerrera ML; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Canning A; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Gustine JN; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Boston University Medical Center, Boston, Massachusetts, USA., Liu S; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Hatcher JM; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Chen J; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Boston University Medical Center, Boston, Massachusetts, USA., Meid K; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Sarosiek S; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Flynn CA; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Branagan AR; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., von Keudell G; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Palomba LM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Castillo JJ; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Yang G; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Treon SP; Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1866-1872. Date of Electronic Publication: 2024 Sep 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
